前收市價 | 200.98 |
開市 | 200.98 |
買盤 | 217.00 |
賣出價 | 226.00 |
拍板 | 600.00 |
到期日 | 2024-05-31 |
今日波幅 | 200.98 - 200.98 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 3 |
These stocks are trading at sky-high valuations which could make them vulnerable to sell-offs.
Eli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all trading in or near buy zones. Medical stocks are often viewed as defensive growth stocks, because their growth is insulated from economic swings due to the government or insurance covering most of the costs. Eli Lilly is in a buy zone while weight-loss drug rival and fellow IBD Leaderboard member Novo Nordisk is setting up.
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), T-Mobile US, Inc. (TMUS) and BHP Group Limited (BHP).